Is IQG-607 a Potential Metallodrug or Metallopro-Drug With a Defined Molecular Target in Mycobacterium tuberculosis?
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is IQG-607 a Potential Metallodrug or Metallopro-Drug With a Defined Molecular Target in Mycobacterium tuberculosis?
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-05-01
DOI
10.3389/fmicb.2018.00880
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical pharmacokinetic profiling of IQG-607, a potential oral metallodrug to treat tuberculosis
- (2018) Adilio da S. Dadda et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Synthesis and mechanistic investigation of iron(II) complexes of isoniazid and derivatives as a redox-mediated activation strategy for anti-tuberculosis therapy
- (2018) Julie Laborde et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Aryl-Substituted Ruthenium(II) Complexes: A Strategy for Enhanced Photocleavage and Efficient DNA Binding
- (2017) Felipe Diógenes Abreu et al. INORGANIC CHEMISTRY
- Photoinitiated treatment of Mycobacterium using Ru(II) isoniazid complexes
- (2017) Robert N. Garner et al. INORGANICA CHIMICA ACTA
- Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugs
- (2017) Giuseppina Salzano et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Photochemical studies of cis -[Ru(bpy) 2 (4-bzpy)(CO)](PF 6 ) 2 and cis -[Ru(bpy) 2 (4-bzpy)(Cl)](PF 6 ): Blue light-induced nucleobase binding
- (2017) Aurideia P. de Sousa et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Drug discovery targeting heme-based sensors and their coupled activities
- (2017) Eduardo Henrique Silva Sousa et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Bis(diphenylphosphino)amines-containing ruthenium cymene complexes as potential anti- Mycobacterium tuberculosis agents
- (2017) Juliana P. da Silva et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Synthesis, Inhibition of Mycobacterium tuberculosis Enoyl-acyl Carrier Protein Reductase and Antimycobacterial Activity of Novel Pentacyanoferrate(II)-isonicotinoylhydrazones
- (2017) Thais Gazzi et al. JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY
- Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis
- (2017) Medea Gegia et al. LANCET INFECTIOUS DISEASES
- Nano-Formulation of Ethambutol with Multifunctional Graphene Oxide and Magnetic Nanoparticles Retains Its Anti-Tubercular Activity with Prospects of Improving Chemotherapeutic Efficacy
- (2017) Bullo Saifullah et al. MOLECULES
- Inhibitory activity of pentacyano(isoniazid)ferrate(II), IQG-607, against promastigotes and amastigotes forms of Leishmania braziliensis
- (2017) Camila F. Amorim et al. PLoS One
- Toxicological profile of IQG-607 after single and repeated oral administration in minipigs: An essential step towards phase I clinical trial
- (2017) Valnês S. Rodrigues-Junior et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Preclinical safety evaluation of IQG-607 in rats: Acute and repeated dose toxicity studies
- (2017) Valnês S. Rodrigues-Junior et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Combatting AMR: photoactivatable ruthenium(ii)-isoniazid complex exhibits rapid selective antimycobacterial activity
- (2017) Nichola A. Smith et al. Chemical Science
- Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles
- (2017) Joana Costa-Gouveia et al. Scientific Reports
- Thiol-Activated HNO Release from a Ruthenium Antiangiogenesis Complex and HIF-1α Inhibition for Cancer Therapy
- (2016) Eduardo Henrique Silva Sousa et al. ACS Chemical Biology
- The formulation of nanomedicines for treating tuberculosis
- (2016) Ana Costa et al. ADVANCED DRUG DELIVERY REVIEWS
- Non-clinical studies in the process of new drug development - Part II: Good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies
- (2016) E.L. Andrade et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Hydroxyl Radical Generation and DNA Nuclease Activity: A Mechanistic Study Based on a Surface-Immobilized Copper Thioether Clip-Phen Derivative
- (2016) Adolfo I. B. Romo et al. CHEMISTRY-A EUROPEAN JOURNAL
- PhotoCORMs: CO release moves into the visible
- (2016) Mark A. Wright et al. DALTON TRANSACTIONS
- Zidovudine and isoniazid induced liver toxicity and oxidative stress: Evaluation of mitigating properties of silibinin
- (2016) Ramanathan Raghu et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis
- (2016) Ameeruddin Nusrath Unissa et al. INFECTION GENETICS AND EVOLUTION
- Azido- and chlorido-cobalt complex as carrier-prototypes for antitumoral prodrugs
- (2016) Bianca M. Pires et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Ethionamide biomimetic activation and an unprecedented mechanism for its conversion into active and non-active metabolites
- (2016) Julie Laborde et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- The in vitro mechanisms of isoniazid and ethionamide resistance poorly reflect those in vivo in Mycobacterium tuberculosis
- (2016) Florence Brossier et al. TUBERCULOSIS
- Norbornene derived nanocarrier reduces isoniazid mediated liver toxicity: assessment in HepG2 cell line and zebrafish model
- (2016) Thangam Anju et al. RSC Advances
- Tuberculosis
- (2016) Madhukar Pai et al. Nature Reviews Disease Primers
- Isoniazid metabolism and hepatotoxicity
- (2016) Pengcheng Wang et al. Acta Pharmaceutica Sinica B
- Ruthenium complexes as antimicrobial agents
- (2015) Fangfei Li et al. CHEMICAL SOCIETY REVIEWS
- Non-nitric oxide based metallovasodilators: synthesis, reactivity and biological studies
- (2015) Denise S. Sá et al. DALTON TRANSACTIONS
- Antitubercular activity of Ru (II) isoniazid complexes
- (2015) Inara de Aguiar et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Metallodrugs in Medicinal Inorganic Chemistry
- (2014) Katja Dralle Mjos et al. CHEMICAL REVIEWS
- Metal complexes as structural templates for targeting proteins
- (2014) Markus Dörr et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Tuberculosis drug discovery in the post-post-genomic era
- (2014) Benoit Lechartier et al. EMBO Molecular Medicine
- Nanostructured drug delivery for better management of tuberculosis
- (2014) Indu Pal Kaur et al. JOURNAL OF CONTROLLED RELEASE
- [Fe(CN)5(isoniazid)]3−: An iron isoniazid complex with redox behavior implicated in tuberculosis therapy
- (2014) Eduardo Henrique Silva Sousa et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells
- (2014) Véronique Dartois NATURE REVIEWS MICROBIOLOGY
- A medicinal chemists’ guide to the unique difficulties of lead optimization for tuberculosis
- (2013) Véronique Dartois et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Exploration of the medical periodic table: towards new targets
- (2013) Nicolas P. E. Barry et al. CHEMICAL COMMUNICATIONS
- IQG-607 abrogates the synthesis of mycolic acids and displays intracellular activity against Mycobacterium tuberculosis in infected macrophages
- (2013) Valnês S. Rodrigues-Junior et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis
- (2013) Eleonora Maretti et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
- (2013) Kevin Pethe et al. NATURE MEDICINE
- Redox activation of metal-based prodrugs as a strategy for drug delivery
- (2012) Nora Graf et al. ADVANCED DRUG DELIVERY REVIEWS
- Systematic Analysis of Pyrazinamide-Resistant Spontaneous Mutants and Clinical Isolates of Mycobacterium tuberculosis
- (2012) Karolien Stoffels et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Targeted Intracellular Delivery of Antituberculosis Drugs to Mycobacterium tuberculosis-Infected Macrophages via Functionalized Mesoporous Silica Nanoparticles
- (2012) Daniel L. Clemens et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Meta-Analysis of Clinical Studies Supports the Pharmacokinetic Variability Hypothesis for Acquired Drug Resistance and Failure of Antituberculosis Therapy
- (2012) Jotam G. Pasipanodya et al. CLINICAL INFECTIOUS DISEASES
- Towards a new tuberculosis drug: pyridomycin - nature's isoniazid
- (2012) Ruben C. Hartkoorn et al. EMBO Molecular Medicine
- Activity of IQG-607, a new orally active compound, in a murine model of Mycobacterium tuberculosis infection
- (2012) Valnês S. Rodrigues-Junior et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- From Conventional to Unusual Enzyme Inhibitor Scaffolds: The Quest for Target Specificity
- (2011) Eric Meggers ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Ruthenium(II) phosphine/diimine/picolinate complexes: Inorganic compounds as agents against tuberculosis
- (2011) Fernando R. Pavan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Isoniazid metal complex reactivity and insights for a novel anti-tuberculosis drug design
- (2011) Eduardo Henrique Silva Sousa et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Biological activity of ruthenium nitrosyl complexes
- (2011) Elia Tfouni et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- The Mycobacterium Tuberculosis FAS-II Dehydratases and Methyltransferases Define the Specificity of the Mycolic Acid Elongation Complexes
- (2011) Sylvain Cantaloube et al. PLoS One
- Iridium Complex with Antiangiogenic Properties
- (2010) Alexander Wilbuer et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Nervous System Effects of Antituberculosis Therapy
- (2010) Joseph S. Kass et al. CNS DRUGS
- Tailoring NO Donors Metallopharmaceuticals: Ruthenium Nitrosyl Ammines and Aliphatic Tetraazamacrocycles
- (2010) E. Tfouni et al. CURRENT MEDICINAL CHEMISTRY
- Mannosylated gelatin nanoparticles bearing isoniazid for effective management of tuberculosis
- (2010) Gaurav Kant Saraogi et al. JOURNAL OF DRUG TARGETING
- An inorganic complex that inhibits Mycobacterium tuberculosis enoyl reductase as a prototype of a new class of chemotherapeutic agents to treat tuberculosis
- (2010) Luiz A. Basso et al. JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY
- Nanobead-based interventions for the treatment and prevention of tuberculosis
- (2010) Gareth Griffiths et al. NATURE REVIEWS MICROBIOLOGY
- Isoniazid-resistance conferring mutations inMycobacterium tuberculosisKatG: Catalase, peroxidase, and INH-NADH adduct formation activities
- (2010) Christine E. Cade et al. PROTEIN SCIENCE
- The utility of the minipig as an animal model in regulatory toxicology
- (2010) Gerd Bode et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Scavenger receptors: role in innate immunity and microbial pathogenesis
- (2009) Thomas Areschoug et al. CELLULAR MICROBIOLOGY
- Targeting proteins with metal complexes
- (2009) Eric Meggers CHEMICAL COMMUNICATIONS
- Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance
- (2009) Indra L. Bergval et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antibiotic Resistance inMycobacterium tuberculosis
- (2009) Javier Suarez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effect of vitamin C on oxidative liver injury due to isoniazid in rats
- (2009) Yakup Ergul et al. PEDIATRICS INTERNATIONAL
- Standardized Treatment of Active Tuberculosis in Patients with Previous Treatment and/or with Mono-resistance to Isoniazid: A Systematic Review and Meta-analysis
- (2009) Dick Menzies et al. PLOS MEDICINE
- New trends for metal complexes with anticancer activity
- (2008) Pieter CA Bruijnincx et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Isoniazid
- (2008) TUBERCULOSIS
- Rifampicin exacerbates isoniazid-induced toxicity in human but not in rat hepatocytes in tissue-like cultures
- (2007) C Shen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug
- (2004) Lee Jia et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started